General Information of the Molecule (ID: Mol01036)
Name
Penicillin-binding protein 1A (PBP1A) ,Streptococcus pneumoniae
Synonyms
PBP-1A; Exported protein 2; Peptidoglycan TGase; DD-transpeptidase; exp2; ponA; spr0329
    Click to Show/Hide
Molecule Type
Protein
Gene Name
pbpA
Gene ID
60234246
Sequence
MNKPTILRLIKYLSISFLSLVIAAIVLGGGVFFYYVSKAPSLSESKLVATTSSKIYDNKN
QLIADLGSERRVNAQANDIPTDLVKAIVSIEDHRFFDHRGIDTIRILGAFLRNLQSNSLQ
GGSALTQQLIKLTYFSTSTSDQTISRKAQEAWLAIQLEQKATKQEILTYYINKVYMSNGN
YGMQTAAQNYYGKDLNNLSLPQLALLAGMPQAPNQYDPYSHPEAAQDRRNLVLSEMKNQG
YISAEQYEKAVNTPITDGLQSLKSASNYPAYMDNYLKEVINQVEEETGYNLLTTGMDVYT
NVDQEAQKHLWDIYNTDEYVAYPDDELQVASTIVDVSNGKVIAQLGARHQSSNVSFGINQ
AVETNRDWGSTMKPITDYAPALEYGVYESTATIVHDEPYNYPGTNTPVYNWDRGYFGNIT
LQYALQQSRNVPAVETLNKVGLNRAKTFLNGLGIDYPSIHYSNAISSNTTESDKKYGASS
EKMAAAYAAFANGGTYYKPMYIHKVVFSDGSEKEFSNVGTRAMKETTAYMMTDMMKTVLS
YGTGRNAYLAWLPQAGKTGTSNYTDEEIENHIKTSQFVAPDELFAGYTRKYSMAVWTGYS
NRLTPLVGNGLTVAAKVYRSMMTYLSEGSNPEDWNIPEGLYRNGEFVFKNGARSTWSSPA
PQQPPSTESSSSSSDSSTSQSSSTTPSTNNSTTTNPNNNTQQSNTTPDQQNQNPQPAQP
    Click to Show/Hide
Function
Cell wall formation.
    Click to Show/Hide
Uniprot ID
PBPA_STRR6
        Click to Show/Hide the Complete Species Lineage
Kingdom: N.A.
Phylum: Firmicutes
Class: Bacilli
Order: Lactobacillales
Family: Streptococcaceae
Genus: Streptococcus
Species: Streptococcus pneumoniae
Type(s) of Resistant Mechanism of This Molecule
  ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
Click to Show/Hide the Full List of Drugs
Amoxicillin
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Disease Class: Streptococcus pneumoniae infection [1]
Resistant Disease Streptococcus pneumoniae infection [ICD-11: AA80.2]
Resistant Drug Amoxicillin
Molecule Alteration Missense mutation
p.S351A
Experimental Note Identified from the Human Clinical Data
In Vitro Model Streptococcus pneumoniae isolates 1313
Experiment for
Molecule Alteration
PCR amplification and sequence alignments assay
Experiment for
Drug Resistance
Correspondence discriminant assay
Mechanism Description The efficacy of Beta-lactam antibiotics in Streptococcus pneumoniae has been compromised because of the development of altered penicillin-binding proteins (PBPs).
Disease Class: Streptococcus pneumoniae infection [1]
Resistant Disease Streptococcus pneumoniae infection [ICD-11: AA80.2]
Resistant Drug Amoxicillin
Molecule Alteration Missense mutation
p.S575T
Experimental Note Identified from the Human Clinical Data
In Vitro Model Streptococcus pneumoniae isolates 1313
Experiment for
Molecule Alteration
PCR amplification and sequence alignments assay
Experiment for
Drug Resistance
Correspondence discriminant assay
Mechanism Description The efficacy of Beta-lactam antibiotics in Streptococcus pneumoniae has been compromised because of the development of altered penicillin-binding proteins (PBPs).
Disease Class: Streptococcus pneumoniae infection [1]
Resistant Disease Streptococcus pneumoniae infection [ICD-11: AA80.2]
Resistant Drug Amoxicillin
Molecule Alteration Missense mutation
p.N609D
Experimental Note Identified from the Human Clinical Data
In Vitro Model Streptococcus pneumoniae isolates 1313
Experiment for
Molecule Alteration
PCR amplification and sequence alignments assay
Experiment for
Drug Resistance
Correspondence discriminant assay
Mechanism Description The efficacy of Beta-lactam antibiotics in Streptococcus pneumoniae has been compromised because of the development of altered penicillin-binding proteins (PBPs).
Disease Class: Streptococcus pneumoniae infection [1]
Resistant Disease Streptococcus pneumoniae infection [ICD-11: AA80.2]
Resistant Drug Amoxicillin
Molecule Alteration Missense mutation
p.E512K
Experimental Note Identified from the Human Clinical Data
In Vitro Model Streptococcus pneumoniae isolates 1313
Experiment for
Molecule Alteration
PCR amplification and sequence alignments assay
Experiment for
Drug Resistance
Correspondence discriminant assay
Mechanism Description The efficacy of Beta-lactam antibiotics in Streptococcus pneumoniae has been compromised because of the development of altered penicillin-binding proteins (PBPs).
Ceftobiprole
Click to Show/Hide
Drug Resistance Data Categorized by Their Corresponding Mechanisms
       Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Disease Class: Community-acquired pneumonia [2], [3], [4]
Resistant Disease Community-acquired pneumonia [ICD-11: CA40.2]
Resistant Drug Ceftobiprole
Molecule Alteration Missense mutation
STMK motif p.T >A +SRNVP motif p.P >T
Experimental Note Identified from the Human Clinical Data
In Vitro Model Streptococcus pneumoniae isolates 1313
Experiment for
Molecule Alteration
Genome sequence assay
Experiment for
Drug Resistance
MIC assay
Mechanism Description Beta-Lactam resistance in S. pneumoniae is caused by mutations in the penicillin-binding domains of one or more of its six penicillin-binding proteins (PBPs) resulting from point mutations or mosaic genes. Altered PBP 1a, PBP 2x, and PBP 2b are the most important PBPs for Beta-lactam resistance among clinical isolates.
References
Ref 1 Positive selection in penicillin-binding proteins 1a, 2b, and 2x from Streptococcus pneumoniae and its correlation with amoxicillin resistance development. Infect Genet Evol. 2008 May;8(3):331-9. doi: 10.1016/j.meegid.2008.02.001. Epub 2008 Feb 14.
Ref 2 Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2006 Nov;50(11):3638-45. doi: 10.1128/AAC.00626-06. Epub 2006 Aug 28.
Ref 3 Resistance to Beta-Lactams in Neisseria ssp Due to Chromosomally Encoded Penicillin-Binding Proteins. Antibiotics (Basel). 2016 Sep 28;5(4):35. doi: 10.3390/antibiotics5040035.
Ref 4 Crystal structures of penicillin-binding protein 2 from penicillin-susceptible and -resistant strains of Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic resistance. J Biol Chem. 2009 Jan 9;284(2):1202-12. doi: 10.1074/jbc.M805761200. Epub 2008 Nov 4.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.